Abstract
The molecular profile of epithelial–myoepithelial carcinomas (EMCa) has not been well studied, though a recent association with Harvey rat sarcoma viral oncogene homolog (HRAS) mutations has been noted. To confirm and validate this, we surveyed fifteen EMCa for HRAS codon 61 mutations and correlated HRAS status with clinicopathologic parameters. There were 11 females and 4 males and mean patient age was 64 (range 49–90). Parotid gland was most commonly involved (n = 10) and the most common histologic appearance was that of a ‘classic’ EMCa (7/15). Four of fifteen (26.7 %) cases demonstrated local recurrence, while 2/15 (13.3 %) demonstrated distant metastases. Other variant morphologies included EMCa arising from pleomorphic adenoma (3/15), and high grade EMCa (2/15). HRAS exon 3, codon 61 mutations, p.Q61R (n = 3) and p.Q61 K (n = 1) were identified in 4 of 15 successfully tested EMCAs (14 patients). Two cases were classic type, while the other cases consisted of one oncocytic variant, and one tumor with myoepithelial overgrowth, the latter of which showed the same mutation in both the primary and recurrence. Of note, the high grade EMCa and EMCa ex pleomorphic adenoma were negative for mutations. Given the small number of cases, there were no significant differences between mutation positive and mutation negative cases in terms of age, gender and outcome.
Similar content being viewed by others
References
Prior IA, Lewis PD, Mattos C. A comprehensive survey of Ras mutations in cancer. Cancer Res. 2012;72(10):2457–67. doi:10.1158/0008-5472CAN112612.
Nielsen LL, Discafani CM, Gurnani M, Tyler RD. Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-Ras oncogene. Cancer Res. 1991;51(14):3762–7.
Milasin J, Pujic N, Dedovic N, Gavric M, Vranic V, Petrovic V, et al. H-Ras gene mutations in salivary gland pleomorphic adenomas. Int J Oral Maxillofac Surg. 1993;22(6):359–61.
Cros JF, Blons H, Sbidian E, Tartour E, Hans S, Brasnu D, et al. Expression and prognostic significance of directed therapy targets and mutational analysis of the EGFR pathway in malignant salivary gland tumors. J Clin Oncol. 2012;30(Suppl):5554.
Deguchi H, Hamano H, Hayashi Y. c-myc, ras p21 and p53 expression in pleomorphic adenoma and its malignant form of the human salivary glands. Acta Pathol Jpn. 1993;43(7–8):413–22.
Wang J, Dong F, Wang X. Quantitative studies of oncogene ras P21 and P53 gene protein expression in the benign and malignant pleomorphic adenomas of salivary gland]. Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi. Chin J Stomatol. 1997;32(4):208–11.
Augello C, Gregorio V, Bazan V, Cammareri P, Agnese V, Cascio S, et al. TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. J Cell Physiol. 2006;207(3):654–9. doi:10.1002/jcp20601.
Donath K, Seifert G, Schmitz R. Diagnosis and ultrastructure of the tubular carcinoma of salivary gland ducts. Epithelial–myoepithelial carcinoma of the intercalated ducts. Virchows Arch A Pathol Pathol Anat. 1972;356(1):16–31.
Seethala RR, Richmond JA, Hoschar AP, Barnes EL. New variants of epithelial–myoepithelial carcinoma: oncocytic-sebaceous and apocrine. Arch Pathol Lab Med. 2009;133(6):950–9. doi:10.1043/15432165133695020080260OAR1.
Seethala RR, Barnes EL, Hunt JL. Epithelial–myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aero digestive tract. Am J Surg Pathol. 2007;31(1):44–57. doi:10.1097/01pas000021331474423d80000047820070100000005.
Fonseca I, Soares J. Epithelial–myoepithelial carcinoma. In: Barnes EL, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization Classification of Tumours: Pathology and Genetics Head and Neck Tumours. Lyon: IARCPress; 2005. p. 225–6.
Roy P, Bullock MJ, Perez-Ordonez B, Dardick I, Weinreb I. Epithelial–myoepithelial carcinoma with high grade transformation. Am J Surg Pathol. 2010;34(9):1258–65. doi:10.1097/PAS0b013e3181e366d2.
Prince ME, Ubell ML, Castro J, Ogawa H, Ogawa T, Narayan A, et al. Tissue-preserving approach to extracting DNA from paraffin-embedded specimens using tissue microarray technology. Head Neck. 2007;29(5):465–71. doi:10.1002/hed20547.
Yoo J, Robinson RA. Ras gene mutations in salivary gland tumors. Arch Pathol Lab Med. 2000;124(6):836–9. doi:http://www.ncbi.nlm.nih.gov/pubmed/10835516.
Yoo J, Robinson RA. H-Ras gene mutations in salivary gland mucoepidermoid carcinomas. Cancer. 2000;88(3):518–23.
van Halteren HK, Top B, Mooi WJ, Balm AJ, Rodenhuis S. Association of H-ras mutations with adenocarcinomas of the parotid gland. Int J Cancer. 1994;57(3):362–4.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chiosea, S.I., Miller, M. & Seethala, R.R. HRAS Mutations in Epithelial–Myoepithelial Carcinoma. Head and Neck Pathol 8, 146–150 (2014). https://doi.org/10.1007/s12105-013-0506-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12105-013-0506-4